Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study - PubMed (original) (raw)
Comparative Study
Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study
J Craig Longenecker et al. J Am Soc Nephrol. 2002 Jul.
Abstract
Although atherosclerotic cardiovascular disease (ASCVD) risk in end-stage renal disease (ESRD) is 5 to 30 times that of the general population, few data exist comparing ASCVD risk factors among new dialysis patients to the general population. This cross-sectional study of 1041 dialysis patients describes the prevalence of ASCVD risk factors at the beginning of ESRD compared with estimates of ASCVD risk factors in the adult US population derived from the Third National Health and Nutrition Examination (NHANES III). CHOICE Study participants had a high prevalence of diabetes (54%), hypertension (96%), left ventricular hypertrophy by electrocardiogram (EKG) criteria (22%), low physical activity (80%), hypertriglyceridemia (36%), and low HDL cholesterol (33%). CHOICE participants were more likely to be older, black, and male than NHANES III participants. After adjustment for age, race, gender, and ASCVD (defined as myocardial infarction, revascularization procedure, stroke, carotid endarterectomy, and amputation in CHOICE; and as myocardial infarction and stroke in NHANES III), the prevalence of diabetes, hypertension, left ventricular hypertrophy by EKG, low physical activity, low HDL cholesterol, and hypertriglyceridemia were still more common in CHOICE participants. Smoking, obesity, hypercholesterolemia, and high LDL cholesterol, however, were less common in CHOICE than NHANES III participants. The projected 5-yr ASCVD risk based on the Framingham Risk Equation among those older than 40 yr without ASCVD was higher in CHOICE Study participants (13%) than in the NHANES III participants (6%). In summary, many ASCVD risk factors are more prevalent in ESRD than in the general population and may explain some, but probably not all, of the increased ASCVD risk in ESRD.
Similar articles
- Lipoprotein(a) and prevalent cardiovascular disease in a dialysis population: The Choices for Healthy Outcomes in Caring for ESRD (CHOICE) study.
Longenecker JC, Coresh J, Marcovina SM, Powe NR, Levey AS, Giaculli F, Fink NE, Klag MJ. Longenecker JC, et al. Am J Kidney Dis. 2003 Jul;42(1):108-16. doi: 10.1016/s0272-6386(03)00413-x. Am J Kidney Dis. 2003. PMID: 12830462 - High lipoprotein(a) levels and small apolipoprotein(a) size prospectively predict cardiovascular events in dialysis patients.
Longenecker JC, Klag MJ, Marcovina SM, Liu YM, Jaar BG, Powe NR, Fink NE, Levey AS, Coresh J. Longenecker JC, et al. J Am Soc Nephrol. 2005 Jun;16(6):1794-802. doi: 10.1681/ASN.2004110922. Epub 2005 Mar 30. J Am Soc Nephrol. 2005. PMID: 15800123 - Triglyceride-Rich Lipoproteins, Apolipoproteins, and Atherosclerotic Cardiovascular Events Among Patients with Diabetes Mellitus and End-Stage Renal Disease on Hemodialysis.
Lamprea-Montealegre JA, Katz R, Scharnagl H, Silbernagel G, März W, Drechsler C, Wanner C, de Boer IH. Lamprea-Montealegre JA, et al. Am J Cardiol. 2021 Aug 1;152:63-68. doi: 10.1016/j.amjcard.2021.04.023. Epub 2021 Jun 6. Am J Cardiol. 2021. PMID: 34108090 - Treatment of hypertension in renal failure patients: when do we overtreat? When do we undertreat?
Rosansky SJ. Rosansky SJ. Blood Purif. 1996;14(4):315-20. doi: 10.1159/000170279. Blood Purif. 1996. PMID: 8873957 Review. - Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients.
Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD. Kalantar-Zadeh K, et al. Kidney Int. 2003 Mar;63(3):793-808. doi: 10.1046/j.1523-1755.2003.00803.x. Kidney Int. 2003. PMID: 12631061 Review.
Cited by
- Harnessing the power of probiotic strains in functional foods: nutritive, therapeutic, and next-generation challenges.
Anwer M, Wei MQ. Anwer M, et al. Food Sci Biotechnol. 2024 Jun 20;33(9):2081-2095. doi: 10.1007/s10068-024-01630-z. eCollection 2024 Jul. Food Sci Biotechnol. 2024. PMID: 39130669 Free PMC article. Review. - Chronic elevation of cardiac troponin I predicts the extent of coronary disease in hemodialysis patients presenting with acute enzyme elevation.
Taha MB, Taha AB, Dasa O, Alom M, Abdelgadir YH, Winchester DE. Taha MB, et al. Am Heart J Plus. 2021 Apr 20;2:100012. doi: 10.1016/j.ahjo.2021.100012. eCollection 2021 Feb. Am Heart J Plus. 2021. PMID: 38560585 Free PMC article. - Chronic Kidney Disease and Cerebrovascular Pathology: Incidence and Functional Outcomes in Riga East University Hospital.
Zubkova V, Ševčenko A, Miļuhins I, Ķikule I, Haritončenko I, Karelis G. Zubkova V, et al. Medicina (Kaunas). 2024 Jan 27;60(2):219. doi: 10.3390/medicina60020219. Medicina (Kaunas). 2024. PMID: 38399507 Free PMC article. - Risk factors and current state of therapy for anemia after kidney transplantation.
Tang Y, Guo J, Zhou J, Wan Z, Li J, Qiu T. Tang Y, et al. Front Med (Lausanne). 2024 Jan 8;10:1170100. doi: 10.3389/fmed.2023.1170100. eCollection 2023. Front Med (Lausanne). 2024. PMID: 38264045 Free PMC article. Review. - Epidemiology of tobacco use in dialysis patients in France and survey of nephrologists' involvement in counseling on tobacco discontinuation.
Haussaire D, Couchoud C, Elharrar X, Rostoker G. Haussaire D, et al. J Nephrol. 2024 Mar;37(2):451-459. doi: 10.1007/s40620-023-01842-2. Epub 2024 Jan 23. J Nephrol. 2024. PMID: 38253969
Publication types
MeSH terms
Grants and funding
- K08-HL 03896/HL/NHLBI NIH HHS/United States
- K24-DK 02643/DK/NIDDK NIH HHS/United States
- K24-DK 02856/DK/NIDDK NIH HHS/United States
- M01-RR 00052/RR/NCRR NIH HHS/United States
- R01-DK 07024/DK/NIDDK NIH HHS/United States
- R01-DK 53869/DK/NIDDK NIH HHS/United States
- R29-DK 48362/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical